Lagano Roxanne

SEC source: 0001555280-21-000036 · wf-form4_161308486296983.xml · derivative · entry 1

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,747.6396

Underlying: Common Stock · 5,747.6396 shares

Expires not disclosed

F1 · security: Represents performance award units with a three-year performance period covering 2018-2020 that were granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 9, 2021, which is the date the Zoetis Human Resources Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) will vest and be settled in shares of Zoetis common stock on February 13, 2021, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F2 · derivative.exercise_price: Each performance award unit represents a contingent right to receive one share of Zoetis Inc. common stock.

F3 · derivative.exercise_date: Each performance award unit will vest and be settled in shares of Zoetis Inc. common stock on February 13, 2021, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F4 · derivative.expiration_date: Not applicable.

SEC source: 0001555280-21-000014 · wf-form4_161118270349900.xml · derivative · entry 1

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,876.96

Underlying: Common Stock · 46.6607 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

SEC source: 0001555280-20-000320 · wf-form4_160590885557121.xml · derivative · entry 3

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,598

Underlying: Common Stock · 6,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F4 · derivative.exercise_price: 6,000 options granted February 19, 2016 at an exercise price of $41.83 per option.

F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F7 · balance_after: 7,362 options granted February 19, 2016 at an exercise price of $41.83 per option; 17,482 options granted February 14, 2017 at an exercise price of $55.02 per option; 13,964 options granted February 13, 2018 at an exercise price of $73.24 per option; 12,052 options granted February 12, 2019 at an exercise price of $87.51 per option; and 7,738 options granted February 11, 2020 at an exercise price of $144.03 per option.

SEC source: 0001555280-20-000320 · wf-form4_160590885557121.xml · nonDerivative · entry 2

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,680

F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $163.70 to $164.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001555280-20-000320 · wf-form4_160590885557121.xml · nonDerivative · entry 1

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,680

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2020.

SEC source: 0001555280-20-000299 · wf-form4_160262452717278.xml · derivative · entry 1

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,727.2676

Underlying: Common Stock · 39.0593 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

SEC source: 0001555280-20-000267 · wf-form4_159804164399239.xml · derivative · entry 3

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,598

Underlying: Common Stock · 6,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F4 · derivative.exercise_price: 6,000 options granted February 19, 2016 at an exercise price of $41.83 per option.

F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F7 · balance_after: 13,362 options granted February 19, 2016 at an exercise price of $41.83 per option; 17,482 options granted February 14, 2017 at an exercise price of $55.02 per option; 13,964 options granted February 13, 2018 at an exercise price of $73.24 per option; 12,052 options granted February 12, 2019 at an exercise price of $87.51 per option; and 7,738 options granted February 11, 2020 at an exercise price of $144.03 per option.

SEC source: 0001555280-20-000267 · wf-form4_159804164399239.xml · nonDerivative · entry 2

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,680

F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $160.04 to $161.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001555280-20-000267 · wf-form4_159804164399239.xml · nonDerivative · entry 1

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,680

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2020.

SEC source: 0001555280-20-000236 · wf-form4_159536337559576.xml · derivative · entry 1

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,601.6293

Underlying: Common Stock · 52.1119 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

SEC source: 0001555280-20-000209 · wf-form4_159009235421905.xml · derivative · entry 3

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,598

Underlying: Common Stock · 4,463 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F4 · derivative.exercise_price: 4,463 options granted February 27, 2015 at an exercise price of $46.09 per option.

F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F7 · balance_after: 19,362 options granted February 19, 2016 at an exercise price of $41.83 per option; 17,482 options granted February 14, 2017 at an exercise price of $55.02 per option; 13,964 options granted February 13, 2018 at an exercise price of $73.24 per option; 12,052 options granted February 12, 2019 at an exercise price of $87.51 per option; and 7,738 options granted February 11, 2020 at an exercise price of $144.03 per option.

SEC source: 0001555280-20-000209 · wf-form4_159009235421905.xml · nonDerivative · entry 2

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,680

F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $130.39 to $131.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001555280-20-000209 · wf-form4_159009235421905.xml · nonDerivative · entry 1

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,143

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2019.

SEC source: 0001555280-20-000180 · wf-form4_158715732317398.xml · derivative · entry 1

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,435.106

Underlying: Common Stock · 127.062 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

SEC source: 0001555280-20-000157 · wf-form4_158586863608669.xml · derivative · entry 1

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,031.0076

Underlying: Common Stock · 317.0512 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

SEC source: 0001555280-20-000129 · wf-form4_158223373065764.xml · derivative · entry 3

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,061

Underlying: Common Stock · 4,463 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F4 · derivative.exercise_price: 4,463 options granted February 27, 2015 at an exercise price of $46.09 per option.

F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F7 · balance_after: 4,463 options granted February 27, 2015 at an exercise price of $46.09 per option; 19,362 options granted February 19, 2016 at an exercise price of $41.83 per option; 17,482 options granted February 14, 2017 at an exercise price of $55.02 per option; 13,964 options granted February 13, 2018 at an exercise price of $73.24 per option; 12,052 options granted February 12, 2019 at an exercise price of $87.51 per option; and 7,738 options granted February 11, 2020 at an exercise price of $144.03 per option.

SEC source: 0001555280-20-000129 · wf-form4_158223373065764.xml · nonDerivative · entry 2

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,680

F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $142.83 to $143.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001555280-20-000129 · wf-form4_158223373065764.xml · nonDerivative · entry 1

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,143

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2019.

SEC source: 0001555280-20-000110 · wf-form4_158214852227894.xml · derivative · entry 6

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,859.0414 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · security: Performance award units having a three-year performance period covering 2017-2019 previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 11, 2020, which is the date the Zoetis Compensation Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) vested on February 14, 2020 and were settled in shares of Zoetis common stock.

F2 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit.

F2 · price: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit.

F4 · derivative.exercise_date: Performance award units having a three-year performance period covering 2017-2019 previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 11, 2020, which is the date the Zoetis Compensation Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) vested on February 14, 2020 and were settled in shares of Zoetis common stock.

F4 · derivative.expiration_date: Performance award units having a three-year performance period covering 2017-2019 previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 11, 2020, which is the date the Zoetis Compensation Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) vested on February 14, 2020 and were settled in shares of Zoetis common stock.

SEC source: 0001555280-20-000110 · wf-form4_158214852227894.xml · derivative · entry 5

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,753.9313

Underlying: Common Stock · 4,630.1076 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 4,630.1076 RSUs vested on February 14, 2020; 3,915.3310 RSUs will vest on February 13, 2021; 3,016.6003 RSUs will vest on February 12, 2022; and 1,822 RSUs will vest on February 11, 2023.

F1 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

F3 · derivative.exercise_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 4,630.1076 RSUs vested on February 14, 2020; 3,915.3310 RSUs will vest on February 13, 2021; 3,016.6003 RSUs will vest on February 12, 2022; and 1,822 RSUs will vest on February 11, 2023.

F3 · derivative.expiration_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 4,630.1076 RSUs vested on February 14, 2020; 3,915.3310 RSUs will vest on February 13, 2021; 3,016.6003 RSUs will vest on February 12, 2022; and 1,822 RSUs will vest on February 11, 2023.

SEC source: 0001555280-20-000110 · wf-form4_158214852227894.xml · nonDerivative · entry 4

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,680

SEC source: 0001555280-20-000110 · wf-form4_158214852227894.xml · nonDerivative · entry 3

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,723

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit.

F2 · price: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit.

SEC source: 0001555280-20-000110 · wf-form4_158214852227894.xml · nonDerivative · entry 2

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,864

SEC source: 0001555280-20-000110 · wf-form4_158214852227894.xml · nonDerivative · entry 1

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,357

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

SEC source: 0001555280-20-000074 · wf-form4_158163416105909.xml · derivative · entry 3

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,859.0414

Underlying: Common Stock · 6,859.0414 shares

Expires not disclosed

F10 · security: Represents performance award units with a three-year performance period covering 2017-2019 that were granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 11, 2020, which is the date the Zoetis Compensation Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) will vest and be settled in shares of Zoetis common stock on February 14, 2020, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F11 · derivative.exercise_price: Each performance award unit represents a contingent right to receive one share of Zoetis Inc. common stock.

F12 · derivative.exercise_date: Each performance award unit will vest and be settled in shares of Zoetis Inc. common stock on February 14, 2020, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F4 · derivative.expiration_date: Not applicable.

SEC source: 0001555280-20-000074 · wf-form4_158163416105909.xml · derivative · entry 2

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,524

Underlying: Common Stock · 7,738 shares

Expires not disclosed

F6 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F7 · derivative.exercise_price: 8,926 options granted February 27, 2015 at an exercise price of $46.09 per option; 19,362 options granted February 19, 2016 at an exercise price of $41.83 per option; 17,482 options granted February 14, 2017 at an exercise price of $55.02 per option; 13,964 options granted February 13, 2018 at an exercise price of $73.24 per option; 12,052 options granted February 12, 2019 at an exercise price of $87.51 per option; and 7,738 options granted February 11, 2020 at an exercise price of $144.03 per option.

F8 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F9 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F7 · balance_after: 8,926 options granted February 27, 2015 at an exercise price of $46.09 per option; 19,362 options granted February 19, 2016 at an exercise price of $41.83 per option; 17,482 options granted February 14, 2017 at an exercise price of $55.02 per option; 13,964 options granted February 13, 2018 at an exercise price of $73.24 per option; 12,052 options granted February 12, 2019 at an exercise price of $87.51 per option; and 7,738 options granted February 11, 2020 at an exercise price of $144.03 per option.

SEC source: 0001555280-20-000074 · wf-form4_158163416105909.xml · derivative · entry 1

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,384.0389

Underlying: Common Stock · 1,822 shares

Expires not disclosed

F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock.

F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F4 · derivative.expiration_date: Not applicable.

F5 · balance_after: The RSUs vest as follows: 4,630.1076 RSUs will vest on February 14, 2020; 3,915.3310 RSUs will vest on February 13, 2021; 3,016.6003 RSUs will vest on February 12, 2022; and 1,822 RSUs will vest on February 11, 2023.

SEC source: 0001555280-20-000008 · wf-form4_157903789139170.xml · derivative · entry 1

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,024.4322

Underlying: Common Stock · 55.606 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

SEC source: 0001555280-19-000278 · wf-form4_157428536698629.xml · derivative · entry 3

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,786

Underlying: Common Stock · 4,463 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F4 · derivative.exercise_price: 4,463 options granted February 27, 2015 at an exercise price of $46.09 per option.

F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F7 · balance_after: 8,926 options granted February 27, 2015 at an exercise price of $46.09 per option; 19,362 options granted February 19, 2016 at an exercise price of $41.83 per option; 17,482 options granted February 14, 2017 at an exercise price of $55.02 per option; 13,964 options granted February 13, 2018 at an exercise price of $73.24 per option; and 12,052 options granted February 12, 2019 at an exercise price of $87.51 per option.

SEC source: 0001555280-19-000278 · wf-form4_157428536698629.xml · nonDerivative · entry 2

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,727

F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.58 to $119.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001555280-19-000278 · wf-form4_157428536698629.xml · nonDerivative · entry 1

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,190

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2019.

SEC source: 0001555280-19-000258 · wf-form4_157117200615417.xml · derivative · entry 1

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,846.1325

Underlying: Common Stock · 50.2964 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

SEC source: 0001555280-19-000230 · wf-form4_156633517317614.xml · derivative · entry 3

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,249

Underlying: Common Stock · 4,463 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F4 · derivative.exercise_price: 4,463 options granted February 27, 2015 at an exercise price of $46.09 per option.

F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F7 · balance_after: 13,389 options granted February 27, 2015 at an exercise price of $46.09 per option; 19,362 options granted February 19, 2016 at an exercise price of $41.83 per option; 17,482 options granted February 14, 2017 at an exercise price of $55.02 per option; 13,964 options granted February 13, 2018 at an exercise price of $73.24 per option; and 12,052 options granted February 12, 2019 at an exercise price of $87.51 per option.

SEC source: 0001555280-19-000230 · wf-form4_156633517317614.xml · nonDerivative · entry 2

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,727

F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.72 to $126.29, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001555280-19-000230 · wf-form4_156633517317614.xml · nonDerivative · entry 1

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,190

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2019.

SEC source: 0001555280-19-000209 · wf-form4_156391291503570.xml · derivative · entry 1

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,685.036

Underlying: Common Stock · 66.0745 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

SEC source: 0001555280-19-000171 · wf-form4_155777981898214.xml · derivative · entry 3

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,712

Underlying: Common Stock · 29,453 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F3 · derivative.exercise_price: 29,453 options granted March 4, 2014 at an exercise price of $30.89 per option.

F4 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F5 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F6 · balance_after: 17,852 options granted February 27, 2015 at an exercise price of $46.09 per option; 19,362 options granted February 19, 2016 at an exercise price of $41.83 per option; 17,482 options granted February 14, 2017 at an exercise price of $55.02 per option; 13,964 options granted February 13, 2018 at an exercise price of $73.24 per option; and 12,052 options granted February 12, 2019 at an exercise price of $87.51 per option.

SEC source: 0001555280-19-000171 · wf-form4_155777981898214.xml · nonDerivative · entry 2

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,727

F1 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.57 to $101.67, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001555280-19-000171 · wf-form4_155777981898214.xml · nonDerivative · entry 1

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,180

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001555280-19-000155 · wf-form4_155544829645091.xml · derivative · entry 1

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,474.5826

Underlying: Common Stock · 155.1616 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

SEC source: 0001555280-19-000141 · wf-form4_155423920162868.xml · derivative · entry 3

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 110,165

Underlying: Common Stock · 2,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F4 · derivative.exercise_price: 2,000 options granted March 4, 2014 at an exercise price of $30.89 per option.

F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F7 · balance_after: 29,453 options granted March 4, 2014 at an exercise price of $30.89 per option; 17,852 options granted February 27, 2015 at an exercise price of $46.09 per option; 19,362 options granted February 19, 2016 at an exercise price of $41.83 per option; 17,482 options granted February 14, 2017 at an exercise price of $55.02 per option; 13,964 options granted February 13, 2018 at an exercise price of $73.24 per option; and 12,052 options granted February 12, 2019 at an exercise price of $87.51.

SEC source: 0001555280-19-000141 · wf-form4_155423920162868.xml · nonDerivative · entry 2

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,727

F2 · price: The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions.

SEC source: 0001555280-19-000141 · wf-form4_155423920162868.xml · nonDerivative · entry 1

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,727

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018.

SEC source: 0001555280-19-000136 · wf-form4_155389188754595.xml · derivative · entry 1

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,981.6051

Underlying: Common Stock · 443.7559 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

SEC source: 0001555280-19-000094 · wf-form4_155078590810237.xml · derivative · entry 6

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,815.4908 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · security: Performance award units having a three-year performance period covering 2016-2018 previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 12, 2019, which is the date the Zoetis Compensation Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) vested on February 19, 2019 and were settled in shares of Zoetis common stock.

F2 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit.

F2 · price: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit.

F4 · derivative.exercise_date: Performance award units having a three-year performance period covering 2016-2018 previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 12, 2019, which is the date the Zoetis Compensation Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) vested on February 19, 2019 and were settled in shares of Zoetis common stock.

F4 · derivative.expiration_date: Performance award units having a three-year performance period covering 2016-2018 previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 12, 2019, which is the date the Zoetis Compensation Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) vested on February 19, 2019 and were settled in shares of Zoetis common stock.

SEC source: 0001555280-19-000094 · wf-form4_155078590810237.xml · derivative · entry 5

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,494.5805

Underlying: Common Stock · 5,289.0903 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 5,289.0903 RSUs vested on February 19, 2019; 4,603.0934 RSUs will vest on February 14, 2020; 3,892.4871 RSUs will vest on February 13, 2021; and 2,999.0000 RSUs will vest on February 12, 2022.

F1 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

F3 · derivative.exercise_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 5,289.0903 RSUs vested on February 19, 2019; 4,603.0934 RSUs will vest on February 14, 2020; 3,892.4871 RSUs will vest on February 13, 2021; and 2,999.0000 RSUs will vest on February 12, 2022.

F3 · derivative.expiration_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 5,289.0903 RSUs vested on February 19, 2019; 4,603.0934 RSUs will vest on February 14, 2020; 3,892.4871 RSUs will vest on February 13, 2021; and 2,999.0000 RSUs will vest on February 12, 2022.

SEC source: 0001555280-19-000094 · wf-form4_155078590810237.xml · nonDerivative · entry 4

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,727

SEC source: 0001555280-19-000094 · wf-form4_155078590810237.xml · nonDerivative · entry 3

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,282

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit.

F2 · price: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit.

SEC source: 0001555280-19-000094 · wf-form4_155078590810237.xml · nonDerivative · entry 2

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,467

SEC source: 0001555280-19-000094 · wf-form4_155078590810237.xml · nonDerivative · entry 1

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,312

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.